Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows Moderna logo (Reuters) -Moderna said on Friday it has filed a marketing application for the review of its ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination COVID and flu shot for people 50 and over, a setback for the company. The Cambridge-based ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data. The maker of the Spikevax Covid-19 ...

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...